Synaptic Retrogenesis and Amyloid-β in Alzheimer's Disease

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Alzheimer's Disease

• Publication date

  2009-01-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3233/JAD-2009-0918PMID 19158416
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alzheimer's disease.

  2011cited by this paper
• The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics

  2009cited by this paper
• Activity-dependent PSD formation and stabilization of newly formed spines in hippocampal slice cultures.

  2008cited by this paper
• Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3.

  2008cited by this paper
• Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo.

  2008cited by this paper
• Amyloid β Protein Dimer-Containing Human CSF Disrupts Synaptic Plasticity: Prevention by Systemic Passive Immunization

  2008influential reference
• Synapse elimination accompanies functional plasticity in hippocampal neurons

  2008cited by this paper
• Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease.

  2007cited by this paper
• A Critical Function for β-Amyloid Precursor Protein in Neuronal Migration Revealed by In Utero RNA Interference

  2007cited by this paper
• Amyloid precursor protein overexpression depresses excitatory transmission through both presynaptic and postsynaptic mechanisms

  2007influential reference
• Aβ Oligomers – a decade of discovery

  2007cited by this paper
• Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease.

  2007cited by this paper
• Natural Oligomers of the Alzheimer Amyloid-β Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway

  2007cited by this paper
• Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease.

  2007cited by this paper
• Increased Neurogenesis in Young Transgenic Mice Overexpressing Human APPSw,Ind

  2007cited by this paper
• Developmental synaptic plasticity at the thalamocortical input to barrel cortex: mechanisms and roles.

  2007cited by this paper
• Soluble Aβ Inhibits Specific Signal Transduction Cascades Common to the Insulin Receptor Pathway*

  2007influential reference
• Aβ Oligomer-Mediated Long-Term Potentiation Impairment Involves Protein Phosphatase 1-Dependent Mechanisms

  2007cited by this paper
• Reversible synaptic depression in developing rat CA3 CA1 synapses explained by a novel cycle of AMPA silencing-unsilencing.

  2007influential reference
• Rapid, concurrent alterations in pre- and postsynaptic structure induced by naturally-secreted amyloid-beta protein.

  2007cited by this paper
• Spatial and temporal control of age-related APP processing in genomic-based beta-secretase transgenic mice.

  2007cited by this paper
• Synapse-specific and developmentally regulated targeting of AMPA receptors by a family of MAGUK scaffolding proteins.

  2006cited by this paper
• Different Conformations of Amyloid β Induce Neurotoxicity by Distinct Mechanisms in Human Cortical Neurons

  2006cited by this paper
• Effects of secreted oligomers of amyloid β‐protein on hippocampal synaptic plasticity: a potent role for trimers

  2006cited by this paper
• Alzheimer's disease

  2006cited by this paper
• AMPA receptor downscaling at the onset of Alzheimer's disease pathology in double knockin mice.

  2006influential reference
• Proteolytic degradation of the amyloid beta-protein: the forgotten side of Alzheimer's disease.

  2006cited by this paper
• A specific amyloid-beta protein assembly in the brain impairs memory.

  2006cited by this paper
• Amyloid beta peptide as a physiological modulator of neuronal 'A'-type K+ current.

  2006cited by this paper
• AMPA and NMDA glutamate receptor trafficking: multiple roads for reaching and leaving the synapse

  2006cited by this paper
• Soluble oligomers of amyloid-β peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway

  2006cited by this paper
• Sorting through the cell biology of Alzheimer's disease: intracellular pathways to pathogenesis.

  2006cited by this paper
• The Functions of Mammalian Amyloid Precursor Protein and Related Amyloid Precursor-Like Proteins

  2006cited by this paper
• Amyloid β peptide adversely affects spine number and motility in hippocampal neurons

  2006cited by this paper
• Synapse Formation and Function Is Modulated by the Amyloid Precursor Protein

  2006cited by this paper
• Inhibition of dynamin-dependent endocytosis increases shedding of the amyloid precursor protein ectodomain and reduces generation of amyloid β protein

  2005cited by this paper
• Regulation of NMDA receptor trafficking by amyloid-beta.

  2005cited by this paper
• Fyn Kinase Induces Synaptic and Cognitive Impairments in a Transgenic Mouse Model of Alzheimer's Disease

  2005cited by this paper
• The amyloid-beta precursor protein: integrating structure with biological function.

  2005cited by this paper
• Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo.

  2005cited by this paper
• Natural oligomers of the amyloid-β protein specifically disrupt cognitive function

  2005cited by this paper
• Alzheimer's disease: Abeta, tau and synaptic dysfunction.

  2005cited by this paper
• Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo.

  2005cited by this paper
• Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses.

  2005cited by this paper
• Abeta42 is essential for parenchymal and vascular amyloid deposition in mice.

  2005cited by this paper
• Physicochemical characteristics of soluble oligomeric Aβ and their pathologic role in Alzheimer's disease

  2005cited by this paper
• Axonal Transport, Amyloid Precursor Protein, Kinesin-1, and the Processing Apparatus: Revisited

  2005cited by this paper
• Repetition of mGluR-dependent LTD causes slowly developing persistent reduction in synaptic strength accompanied by synapse elimination.

  2005cited by this paper
• The role of cell-derived oligomers of Abeta in Alzheimer's disease and avenues for therapeutic intervention.

  2005cited by this paper
• Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease

  2005cited by this paper
• ReportShrinkage of Dendritic Spines Associated with Long-Term Depression of Hippocampal Synapses

  2004cited by this paper
• Structure and function of amyloid in Alzheimer's disease.

  2004cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• Developmental changes in release properties of the CA3-CA1 glutamate synapse in rat hippocampus.

  2004cited by this paper
• Monitoring Clathrin-Mediated Endocytosis during Synaptic Activity

  2004cited by this paper
• Binding Sites of γ-Secretase Inhibitors in Rodent Brain: Distribution, Postnatal Development, and Effect of Deafferentation

  2004cited by this paper
• Amyloid beta prevents activation of calcium/calmodulin-dependent protein kinase II and AMPA receptor phosphorylation during hippocampal long-term potentiation.

  2004cited by this paper
• Neurogenic effect of beta-amyloid peptide in the development of neural stem cells.

  2004cited by this paper
• Creation of AMPA-silent synapses in the neonatal hippocampus

  2004cited by this paper
• Block of Long-Term Potentiation by Naturally Secreted and Synthetic Amyloid β-Peptide in Hippocampal Slices Is Mediated via Activation of the Kinases c-Jun N-Terminal Kinase, Cyclin-Dependent Kinase 5, and p38 Mitogen-Activated Protein Kinase as well as Metabotropic Glutamate Receptor Type 5

  2004cited by this paper
• Members of the Wnt, Fz, and Frp gene families expressed in postnatal mouse cerebral cortex

  2004cited by this paper
• β-Amyloid-Mediated Inhibition of NMDA Receptor-Dependent Long-Term Potentiation Induction Involves Activation of Microglia and Stimulation of Inducible Nitric Oxide Synthase and Superoxide

  2004cited by this paper
• Postsynaptic Density-95 Mimics and Occludes Hippocampal Long-Term Potentiation and Enhances Long-Term Depression

  2003cited by this paper
• A developmental switch in the signaling cascades for LTP induction

  2003cited by this paper
• APP processing and synaptic function.

  2003influential reference
• The Amyloid Precursor Protein and Its Regulatory Protein, FE65, in Growth Cones and Synapses In Vitro and In Vivo

  2003cited by this paper
• Alzheimer's disease proteins in cerebellar and hippocampal synapses during postnatal development and aging of the rat.

  2003influential reference
• Rab5-stimulated Up-regulation of the Endocytic Pathway Increases Intracellular β-Cleaved Amyloid Precursor Protein Carboxyl-terminal Fragment Levels and Aβ Production*

  2003cited by this paper
• Glutamatergic plasticity by synaptic delivery of GluR-B(long)-containing AMPA receptors.

  2003cited by this paper
• The Magnitude of Dementia Occurrence in the World

  2003cited by this paper
• NMDA receptor regulation by amyloid-β does not account for its inhibition of LTP in rat hippocampus

  2003cited by this paper
• Amyloid β-peptide inhibition of the PKA/CREB pathway and long-term potentiation: Reversibility by drugs that enhance cAMP signaling

  2002cited by this paper
• AMPA receptor trafficking and synaptic plasticity.

  2002cited by this paper
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

  2002cited by this paper
• Gene expression pattern Notch1 and its ligands Delta-like and Jagged are expressed and active in distinct cell populations in the postnatal mouse brain

  2002cited by this paper
• Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus.

  2002cited by this paper
• The molecular basis of CaMKII function in synaptic and behavioural memory

  2002cited by this paper
• Alzheimer Amyloid β-Peptide Inhibits the Late Phase of Long-Term Potentiation through Calcineurin-Dependent Mechanisms in the Hippocampal Dentate Gyrus

  2002cited by this paper
• A physiologic signaling role for the gamma -secretase-derived intracellular fragment of APP.

  2002cited by this paper
• Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

  2002cited by this paper
• Hippocampal Amnesia

  2001cited by this paper
• Ontogenetic changes in protein level of amyloid precursor protein (APP) in growth cones and synaptosomes from rat brain and prenatal expression pattern of APP mRNA isoforms in developing rat embryo

  2001influential reference
• PII: S0306-4522(00)00496-6

  2001cited by this paper
• Alzheimer's disease: genes, proteins, and therapy.

  2001cited by this paper
• Total number and distribution of inhibitory and excitatory synapses on hippocampal CA1 pyramidal cells.

  2001cited by this paper
• NMDA receptor subunits: diversity, development and disease.

  2001cited by this paper
• A model of synaptic memory: a CaMKII/PP1 switch that potentiates transmission by organizing an AMPA receptor anchoring assembly.

  2001cited by this paper
• Distinct expression patterns of two zebrafish homologues of the human APP gene during embryonic development

  2001cited by this paper
• Coordinated expression of beta-amyloid precursor protein and the putative beta-secretase BACE and alpha-secretase ADAM10 in mouse and human brain.

  2000cited by this paper
• The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain.

  2000cited by this paper
• Synaptic plasticity and memory: an evaluation of the hypothesis.

  2000cited by this paper
• A Developmental Change in NMDA Receptor-Associated Proteins at Hippocampal Synapses

  2000cited by this paper
• Tau protein isoforms, phosphorylation and role in neurodegenerative disorders.

  2000cited by this paper
• Postnatal synaptic potentiation: Delivery of GluR4-containing AMPA receptors by spontaneous activity

  2000cited by this paper
• Impairment of hippocampal long-term potentiation by Alzheimer amyloid beta-peptides.

  2000cited by this paper
• PKA Phosphorylations on Tau: Developmental Studies in the Mouse

  2000cited by this paper
• Synaptic assembly of the brain in the absence of neurotransmitter secretion.

  2000cited by this paper
• Fresh and globular amyloid beta protein (1-42) induces rapid cellular degeneration: evidence for AbetaP channel-mediated cellular toxicity.

  2000cited by this paper
• Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models.

  1999influential reference
• Retrogenesis: clinical, physiologic, and pathologic mechanisms in brain aging, Alzheimer’s and other dementing processes

  1999cited by this paper

• Investigating the Restricted Dynamical Environment in and Around Aβ Peptide Oligomers in Aqueous Ionic Liquid Solutions.

  2025cites this paper
• Exploring the structure and stability of pentameric amyloid β peptide aggregates in aqueous ammonium-based ionic liquid solutions.

  2025cites this paper
• Empathy enhancement through VR: A practice-led design study

  2024cites this paper
• Single-cell Transcriptomic Analysis Demonstrates the Regulation of Peach Polysaccharides on Circadian Rhythm Disturbance.

  2022cites this paper
• Gut Microbiota Mediates Oolong Tea Polyphenols Alleviation of Circadian Rhythm Disturbance

  2021cites this paper
• Effect of aggregated Aβ protofilaments on intermolecular vibrational spectrum of confined water

  2019cites this paper
• TRPC1 Null Exacerbates Memory Deficit and Apoptosis Induced by Amyloid-β

  2018cites this paper
• Dynamical crossover of water confined within the amphiphilic nanocores of aggregated amyloid β peptides.

  2018cites this paper
• Understanding the microscopic origin behind heterogeneous properties of water confined in and around Aβ17-42 protofilaments.

  2018cites this paper
• Presynaptic Aβ40 prevents synapse addition in the adult Drosophila neuromuscular junction

  2017cites this paper
• Size-Dependent Conformational Features of Aβ17-42 Protofilaments from Molecular Simulation Studies

  2017cites this paper
• In silico studies of the early stages of aggregation of A$$\beta _{42}$$β42 peptides

  2017cites this paper
• In silico studies of the early stages of aggregation of Aβ42 peptides†

  2017cites this paper
• Nitration of Tyrosine Residue Y10 of Aβ1-42 Significantly Inhibits Its Aggregation and Cytotoxicity.

  2017cites this paper
• SAHLGRENSKA ACADEMY Characterization of de novo generated synapses in the adult brain – effects of melanocortin receptor activation Degree Project in Medicine

  2017cites this paper
• Label-Free LC-MS/MS Comparative Analysis of Protein S-Nitrosome in Synaptosomes from Wild-Type and APP Transgenic Mice

  2016cites this paper
• The Role of Mast Cells in Alzheimer's Disease.

  2016cites this paper
• Natural Intracellular Consequences of Amyloid

  2016cites this paper
• The Amyloid Precursor Protein—A Novel Player within the Molecular Array of Presynaptic Nanomachines

  2016cites this paper
• Selective vulnerability in neurodegeneration: insights from clinical variants of Alzheimer's disease

  2016cites this paper
• Brain Amyloid-Beta Fragment Signatures in Pathological Ageing and Alzheimer's Disease by Hybrid Immunoprecipitation Mass Spectrometry

  2015cites this paper
• Amyloid β: one of three danger-associated molecules that are secondary inducers of the proinflammatory cytokines that mediate Alzheimer’s disease

  2015cites this paper
• The proline-rich hypothalamic peptide is a modulator of functions of neurotrophins and neuronal activity in amyloid-induced neurodegeneration

  2014cites this paper
• Synaptic and Sub-Synaptic Localization of Amyloid-β Protein Precursor in the Rat Hippocampus

  2014cites this paper
• AMPA-silent synapses in brain development and pathology

  2013cites this paper
• Can BACE1 Inhibition Mitigate Early Axonal Pathology in Neurological Diseases?

  2013cites this paper
• Key role of mitochondria in Alzheimer's disease synaptic dysfunction.

  2013cites this paper
• Cerebrospinal fluid biomarkers in neurological diseases in children.

  2013cites this paper
• Rapid, Reversible Impairment of Synaptic Signaling in Cultured Cortical Neurons by Exogenously-Applied Amyloid-β

  2013influential citation
• The interplay between vascular and mitochondrial abnormalities in type 2 diabetes and Alzheimer’s disease

  2013influential citation
• Aggregation of Alzheimer's amyloid β-peptide in biological membranes: a molecular dynamics study.

  2013cites this paper
• Determination of Bis(9)-(-)-Meptazinol, a bis-ligand for Alzheimer's disease, in rat plasma by liquid chromatography-tandem mass spectrometry: application to pharmacokinetics study.

  2012cites this paper
• The Comparison of Cognitive and Functional Performance in Children and Alzheimer's Disease Supports the Retrogenesis Model

  2012cites this paper
• The Microtubule-Associated Protein 1A (MAP1A) is an Early Molecular Target of Soluble Aβ-Peptide

  2012cites this paper
• Aβ Toxicity in Alzheimer's Disease

  2012cites this paper
• Enrichment of the inositol 1,4,5-trisphosphate receptor/Ca2+ channels in secretory granules and essential roles of chromogranins.

  2012cites this paper
• Novel aβ isoforms in Alzheimer's disease - their role in diagnosis and treatment.

  2011cites this paper
• Amyloid Beta as a Modulator of Synaptic Plasticity

  2011cites this paper
• From understanding synaptic plasticity to the development of cognitive enhancers.

  2011influential citation
• Amyloid beta 1-42 in cerebrospinal fluid is associated with cognitive plasticity.

  2011cites this paper
• Are Herbal Compounds the Next Frontier for Alleviating Learning and Memory Impairments? An Integrative Look at Memory, Dementia and the Promising Therapeutics of Traditional Chinese Medicines

  2011influential citation
• Focal expression of mutated tau in entorhinal cortex neurons of rats impairs spatial working memory.

  2011cites this paper
• Psicomotricidade e retrogênese: considerações sobre o envelhecimento e a doença de Alzheimer

  2010cites this paper
• Rôle des ADAM dans le processus physiopathologique de la maladie d'Alzheimer

  2010cites this paper
• Distinct cerebrospinal fluid amyloid β peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease

  2010cites this paper
• Alzheimer Psicomotricity and retrogenesis : considerations about aging and Alzheimer ’ s disease

  2010cites this paper
• LPYFDa Neutralizes Amyloid-β-Induced Memory Impairment and Toxicity

  2010cites this paper
• Amyloid-β as a Modulator of Synaptic Plasticity

  2010cites this paper
• Converging molecular pathways in human neural development and degeneration.

  2010cites this paper
• Assessing the stability of Alzheimer's amyloid protofibrils using molecular dynamics.

  2010cites this paper
• Beta-amyloid: a disease target or a synaptic regulator affecting age-related neurotransmitter changes?

  2010cites this paper
• Converging Pathways of Chromogranin and Amyloid Metabolism in the Brain

  2010cites this paper
• Herpes simplex virus type 1 persists in the aged brain through hypothetical expression of accessory genes

  2010cites this paper
• Amyloid beta and APP as biomarkers for Alzheimer's disease.

  2010cites this paper
• Destabilizing Alzheimer's Abeta(42) protofibrils with morin: mechanistic insights from molecular dynamics simulations.

  2010cites this paper
• Development of novel small-size peptides as putative therapeutic drugs

  2010cites this paper
• Title Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN 1 A 431 E-associated familial Alzheimer ' s disease Permalink

  2010cites this paper
• Oral Treatment with a γ-Secretase Inhibitor Improves Long-Term Potentiation in a Mouse Model of Alzheimer's Disease

  2010cites this paper
• Oral Treatment with a (cid:1) -Secretase Inhibitor Improves Long-Term Potentiation in a Mouse Model of Alzheimer’s Disease

  2010cites this paper
• Alzheimer’s Disease Amyloid β-Protein and Synaptic Function

  2010cites this paper
• As Bad as its Reputation ? The Physiological Function of Amyloid Precursor Protein and Amyloid-β Bachelor

  2009cites this paper
• CSF Biomarkers

  2009cites this paper
• Endosomes élargis et cholestérol : De la trisomie 21 à la maladie d'Alzheimer

  2009cites this paper
• Age, neuropathology, and dementia.

  2009cites this paper